BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11510986)

  • 1. Tracking prostate carcinoma micrometastasis to multiple organs using histochemical marker genes and novel cell systems.
    Culp LA; Holleran JL; Miller CJ
    Histol Histopathol; 2001 Jul; 16(3):945-53. PubMed ID: 11510986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking micrometastasis to multiple organs with lacZ-tagged CWR22R prostate carcinoma cells.
    Holleran JL; Miller CJ; Culp LA
    J Histochem Cytochem; 2000 May; 48(5):643-51. PubMed ID: 10769048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential experimental micrometastasis to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma cells.
    Holleran JL; Miller CJ; Edgehouse NL; Pretlow TP; Culp LA
    Clin Exp Metastasis; 2002; 19(1):17-24. PubMed ID: 11918079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor progression, micrometastasis, and genetic instability tracked with histochemical marker genes.
    Culp LA; Lin WC; Kleinman NR; Campero NM; Miller CJ; Holleran JL
    Prog Histochem Cytochem; 1998; 33(3-4):XI-XV, 329-48. PubMed ID: 10319377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression.
    Lin WC; Pretlow TP; Pretlow TG; Culp LA
    Cancer Res; 1990 May; 50(9):2808-17. PubMed ID: 2183931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of micrometastases: earliest events detected with bacterial lacZ gene-tagged tumor cells.
    Lin WC; Pretlow TP; Pretlow TG; Culp LA
    J Natl Cancer Inst; 1990 Sep; 82(18):1497-503. PubMed ID: 2391720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.
    Tsingotjidou AS; Ahluwalia R; Zhang X; Conrad H; Emmanouilides C
    Int J Oncol; 2003 Dec; 23(6):1569-74. PubMed ID: 14612928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
    Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
    Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered establishment/clearance mechanisms during experimental micrometastasis with live and/or disabled bacterial lacZ-tagged tumor cells.
    Lin WC; Culp LA
    Invasion Metastasis; 1992; 12(3-4):197-209. PubMed ID: 1294531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved visualization of lung metastases at single cell resolution in mice by combined in-situ perfusion of lung tissue and X-Gal staining of lacZ-tagged tumor cells.
    Arlt MJ; Born W; Fuchs B
    J Vis Exp; 2012 Aug; (66):e4162. PubMed ID: 22929213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.
    Freedland SJ; Pantuck AJ; Paik SH; Zisman A; Graeber TG; Eisenberg D; McBride WH; Nguyen D; Tso CL; Belldegrun AS
    Prostate; 2003 Jun; 55(4):299-307. PubMed ID: 12712409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ specific Gst-pi expression of the metastatic androgen independent prostate cancer cells in nude mice.
    Naiki T; Asamoto M; Toyoda-Hokaiwado N; Naiki-Ito A; Tozawa K; Kohri K; Takahashi S; Shirai T
    Prostate; 2012 Apr; 72(5):533-41. PubMed ID: 21748757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tagged tumor cells reveal regulatory steps during earliest stages of tumor progression and micrometastasis.
    Culp LA; Lin WC; Kleinman NR
    Histol Histopathol; 1999 Jul; 14(3):879-86. PubMed ID: 10425558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution analyses of two different classes of tumor cells in situ tagged with alternative histochemical marker genes.
    Lin WC; Pretlow TP; Pretlow TG; Culp LA
    Am J Pathol; 1992 Dec; 141(6):1331-42. PubMed ID: 1466397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes.
    Lin WC; O'Connor KL; Culp LA
    Br J Cancer; 1993 May; 67(5):910-21. PubMed ID: 8494724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.
    Soff GA; Sanderowitz J; Gately S; Verrusio E; Weiss I; Brem S; Kwaan HC
    J Clin Invest; 1995 Dec; 96(6):2593-600. PubMed ID: 8675623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of fibroblast growth factor 1 in MCF-7 breast cancer cells facilitates tumor cell dissemination but does not support the development of macrometastases in the lungs or lymph nodes.
    Zhang L; Kharbanda S; McLeskey SW; Kern FG
    Cancer Res; 1999 Oct; 59(19):5023-9. PubMed ID: 10519418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
    Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
    Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.